Vaccination and Treatment for H1N1 Virus in Humans
There currently is no commercially available vaccine to protect
humans against this H1N1 virus. The H1N1 flu virus strains causing the
current outbreak are very different from human H1N1 viruses and,
therefore, vaccines for this past human seasonal flu would not provide
protection from these H1N1 flu viruses.
Antiviral Medication
If you get sick, antiviral drugs can make your illness milder
and make you feel better faster. They may also prevent serious
influenza complications. In treatment, antiviral drugs work best if
started as soon after getting sick as possible, and might not work if
started more than 48 hours after illness starts.
Influenza
antiviral drugs also can be used to prevent influenza when they are
given to a person who is not ill but who has been or may be near a
person with H1N1 influenza. When used to prevent the flu, antiviral
drugs are about 70% to 90% effective. When used for prevention, the
number of days that they should be used will vary depending on a
person's particular situation.
There are four different antiviral
drugs that are licensed for use in the U.S. for the treatment of
influenza. At this time, CDC recommends the use of oseltamivir (brand
name Tamiflu ®) or zanamivir (brand name Relenza ®) for the treatment
and/or prevention of infection with H1N1 influenza viruses. The other
two antivirals, amantadine and rimantadine, are ineffective for
treating the most recent H1N1 flu viruses in humans.